These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis. Stefferl A; Brehm U; Linington C J Neural Transm Suppl; 2000; (58):123-33. PubMed ID: 11128602 [TBL] [Abstract][Full Text] [Related]
16. Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China. Wang L; ZhangBao J; Zhou L; Zhang Y; Li H; Li Y; Huang Y; Wang M; Lu C; Lu J; Zhao C; Quan C Eur J Neurol; 2019 Jan; 26(1):168-174. PubMed ID: 30133068 [TBL] [Abstract][Full Text] [Related]
17. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390 [TBL] [Abstract][Full Text] [Related]